Ausgabe 2/2017
Inhalt (9 Artikel)
Risk Evaluation and Mitigation Strategies (REMSs): Are They Improving Drug Safety? A Critical Review of REMSs Requiring Elements to Assure Safe Use (ETASU)
Pol F. Boudes
Revisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme
Dorota Lubanska, Lisa Porter
In Vitro Diagnosis of Immediate Drug Hypersensitivity Anno 2017: Potentials and Limitations
I. I. Decuyper, E. A. Mangodt, A. L. Van Gasse, K. Claesen, A. Uyttebroek, M. Faber, V. Sabato, C. H. Bridts, C. Mertens, M. M. Hagendorens, L. S. De Clerck, Didier G. Ebo
The Pharmacogenetics of Tacrolimus in Corticosteroid-Sparse Pediatric and Adult Kidney Transplant Recipients
Mads Juul Madsen, Troels K. Bergmann, Kim Brøsen, Helle Charlotte Thiesson
Hyperlipidemia Alters the Pharmacokinetics of Posaconazole and Vincristine Upon Co-Administration in Rats
Hadeel A. Khalil, Mohammed A. W. ElKhatib, Tarek S. Belal, Ahmed F. El-Yazbi, Dalia A. Hamdy
Solubilization and Stability of Mitomycin C Solutions Prepared for Intravesical Administration
Alan L. Myers, Yan-Ping Zhang, Jitesh D. Kawedia, Ximin Zhou, Stacey M. Sobocinski, Michael J. Metcalfe, Mark A. Kramer, Colin P. N. Dinney, Ashish M. Kamat
Manufacturing of Recombinant Human Follicle-Stimulating Hormone Ovaleap® (XM17), Comparability with Gonal-f®, and Performance/Consistency
Rainer Winstel, Juergen Wieland, Beate Gertz, Arnd Mueller, Hermann Allgaier
Canagliflozin as an Initial Therapy in Drug-Naïve Subjects with Type 2 Diabetes Mellitus: A Potential Involvement of Atherogenic Lipids in its Glycemic Efficacy
Eiji Kutoh, Asuka Wada, Teruma Murayama, Yui Takizawa
Psychotropic Drug-Related Fall Incidents in Nursing Home Residents Living in the Eastern Part of The Netherlands
Sarah I. M. Janus, Gezinus H. Reinders, Jeannette G. van Manen, Sytse U. Zuidema, Maarten J. IJzerman